Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03031730 |
| Title | MDM2 Inhibitor AMG-232, Carfilzomib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California Davis Comprehensive Cancer Center | RECRUITING | Sacramento | California | 95817 | United States | Details |
| UCHealth University of Colorado Hospital | ACTIVE_NOT_RECRUITING | Aurora | Colorado | 80045 | United States | Details |
| NYP/Weill Cornell Medical Center | RECRUITING | New York | New York | 10065 | United States | Details |
| University of Texas at Austin | RECRUITING | Austin | Texas | 78712 | United States | Details |
| M D Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
| University of Texas Health Science Center at San Antonio | ACTIVE_NOT_RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| Huntsman Cancer Institute/University of Utah | RECRUITING | Salt Lake City | Utah | 84112 | United States | Details |